Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
ARIAD reports net income of $13.9 million for third quarter 2011

ARIAD reports net income of $13.9 million for third quarter 2011

Study: Melanoma survivors more likely to have new cancers

Study: Melanoma survivors more likely to have new cancers

Viewpoints: GOP intransigence on super committee; taxing health benefits would backfire; the need for care in defining essential benefits

Viewpoints: GOP intransigence on super committee; taxing health benefits would backfire; the need for care in defining essential benefits

Radiation therapy prior to HCT improves outcomes in older patients with hematologic malignancies

Radiation therapy prior to HCT improves outcomes in older patients with hematologic malignancies

Age is no longer a barrier to allogeneic stem cell transplantation

Age is no longer a barrier to allogeneic stem cell transplantation

Tregs expansion can help prevent graft-versus-host disease

Tregs expansion can help prevent graft-versus-host disease

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

Positive initial results from CytRx's INNO-206 Phase 1b/2 clinical trial for advanced solid tumors

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

'Heroes of Hope Race for Brain Tumor Research' event to be held on Nov. 6

'Heroes of Hope Race for Brain Tumor Research' event to be held on Nov. 6

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene

New potential leukemia therapy targets and kills cancer cells

New potential leukemia therapy targets and kills cancer cells

UCR biology professor inducted into American Academy of Arts and Sciences

UCR biology professor inducted into American Academy of Arts and Sciences

Small molecule selectively blocks gene activity regulated by thyroid hormone

Small molecule selectively blocks gene activity regulated by thyroid hormone

Biomarker can help identify GVHD in cancer patients after hematopoietic stem cell transplant

Biomarker can help identify GVHD in cancer patients after hematopoietic stem cell transplant

Two proteins bind together to ignite and sustain malignant brain tumors

Two proteins bind together to ignite and sustain malignant brain tumors

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

Positive results from Roche's Phase 3 HannaH trial for HER2-positive early breast cancer

NEP successfully inserts specific doses of anti-cancer gene into leukemia cells

NEP successfully inserts specific doses of anti-cancer gene into leukemia cells

Delayed appendectomies may increase likelihood of complications in children

Delayed appendectomies may increase likelihood of complications in children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.